AAAAAA
Results: 26-40/40
Authors:
PROSPER F
STRONCEK D
VANOVERBEKE K
VERFAILLIE CM
Citation: F. Prosper et al., PRIMITIVE LTC-IC IN G-CSF MOBILIZED PBPC HAVE SIMILAR IN-VITRO EXPANSION POTENTIAL AS LTC-IC IN STEADY-STATE MARROW, Blood, 88(10), 1996, pp. 1816-1816
Authors:
PROSPER F
STRONCEK D
VERFAILLIE CM
Citation: F. Prosper et al., HOMING OF MOBILIZED PBPC, WHICH ADHERE POORLY TO STROMA DUE TO LOW-LEVELS OF VLA-4, MAY RESULT FROM UP-REGULATION OF EXPRESSION AND FUNCTION OF VLA-4 ONCE PBPC ARE REMOVED FROM THE MOBILIZING MILIEU, Blood, 88(10), 1996, pp. 1889-1889
Authors:
PROSPER F
STRONCEK D
VERFAILLIE CM
Citation: F. Prosper et al., CYTOKINE-INDUCED PROLIFERATION OF G-CSF MOBILIZED PBPC IS INHIBITED BY ADHESION TO BM STROMA THROUGH A BETA-1 INTEGRIN-DEPENDENT MECHANISM, Blood, 88(10), 1996, pp. 2117-2117
Authors:
POSTIGLIONE K
FERRIS R
JAFFE JP
STRONCEK D
Citation: K. Postiglione et al., IMMUNE-MEDIATED AGRANULOCYTOSIS AND ANEMIA ASSOCIATED WITH THYMOMA, American journal of hematology, 49(4), 1995, pp. 336-340
Authors:
LENNON S
ZARNOTH D
HERR G
WARD N
STRONCEK D
Citation: S. Lennon et al., COMPARATIVE-EVALUATION OF LEUKOCYTE FILTER PERFORMANCE FOR PLATELET COMPONENTS, Transfusion, 35(10), 1995, pp. 43-43
Authors:
SWANSON J
MOERTEL C
STRONCEK D
HEISEL M
KEY NS
Citation: J. Swanson et al., SEROLOGICAL EVIDENCE THAT FACTOR-IX INHIBITOR IN THE PLASMA OF HEMOPHILIA-B PATIENTS DETECTS FACTOR-IX ON NORMAL RED-BLOOD-CELLS, Blood, 86(10), 1995, pp. 258-258
Authors:
MCCULLOUGH J
CLAY ME
FAUTSCH S
NOREEN H
SEGALL M
PERRY E
STRONCEK D
Citation: J. Mccullough et al., PROPOSED POLICIES AND PROCEDURES FOR THE ESTABLISHMENT OF A CORD-BLOOD BANK, Blood cells, 20(2-3), 1994, pp. 609-626
Authors:
CALDERWOOD S
BLANCHETTE V
DOYLE J
FREEDMAN J
STRONCEK D
ZIPURSKY A
Citation: S. Calderwood et al., IDIOPATHIC THROMBOCYTOPENIA AND NEUTROPENIA IN CHILDHOOD, The American journal of pediatric hematology/oncology, 16(2), 1994, pp. 95-101
Authors:
MACIAS M
WAYNE A
NELSON R
DAY NK
GOOD RA
STRONCEK D
LALEZARI P
Citation: M. Macias et al., ALLOANTIBODY (AB) MEDIATED NEUTROPENIA AFTER BONE-MARROW TRANSPLANT (BMT) FOR SEVERE COMBINED IMMUNE-DEFICIENCY (SCID), Journal of allergy and clinical immunology, 93(1), 1994, pp. 275-275
Authors:
STRONCEK D
CLAY M
HERR G
MCCULLOUGH J
Citation: D. Stroncek et al., GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) TREATMENT DECREASES THEEXPRESSION OF GRANULOCYTE ALLOANTIGENS, Transfusion, 34(10), 1994, pp. 190000077-190000077
Authors:
STRONCEK D
STRAND R
HOFKES C
MCCULLOUGH J
Citation: D. Stroncek et al., THE CHANGING ACTIVITIES OF A REGIONAL MARROW DONOR PROGRAM, Transfusion, 34(1), 1994, pp. 58-62
Authors:
STRONCEK D
CLAY M
MILLS B
OLDHAM F
MCCULLOUGH J
Citation: D. Stroncek et al., EXPERIENCES OF NORMAL INDIVIDUALS TREATED WITH GRANULOCYTE-COLONY-STIMULATING FACTOR, Blood, 84(10), 1994, pp. 10000349-10000349
Authors:
STRONCEK D
CLAY M
JASZCZ W
MILLS B
OLDHAM F
MCCULLOUGH J
Citation: D. Stroncek et al., LONGER THAN 5 DAYS OF G-CSF MOBILIZATION OF NORMAL INDIVIDUALS RESULTS IN LOWER CD34+ CELL COUNTS, Blood, 84(10), 1994, pp. 10000541-10000541
Authors:
STRONCEK D
BARTSCH G
PERKINS HA
RANDALL BL
HANSEN JA
MCCULLOUGH J
Citation: D. Stroncek et al., THE NATIONAL MARROW DONOR PROGRAM, Transfusion, 33(7), 1993, pp. 567-577
Authors:
MCCULLOUGH J
WAGNER J
PERRY E
FAUTSCH S
CLAY M
NOREEN H
SEGALL M
STRONCEK D
Citation: J. Mccullough et al., ESTABLISHMENT OF A CORD-BLOOD BANK, Blood, 82(10), 1993, pp. 10000393-10000393